Pancreatic Cancer Research

ResearcherUniversity of ArizonaNo recent work listed

Bernard W. Futscher

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8367-434X; OpenAlex author ID A5029797248; NIH RePORTER profile ID 1894092. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 grant

Papers 2

  1. Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease. First author DOI 10.1186/s13148-022-01246-2↗
  2. Transcriptional regulation of SLIT2 expression in pancreatic cancer cell lines Co-author DOI 10.1101/2020.09.29.319129↗

Grants 1

  1. DNA methylation, Liquid Biopsy, and Pancreatic Cancer R21CA263132↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rachna T. Shroff · 1 shared paper, 1 shared grant, 2022–2023 · strength 0.75
  2. Mark A. Nelson · 1 shared paper, 1 shared grant, 2022–2023 · strength 0.75
  3. Lukáš Vrba · 2 shared papers, 2020–2022 · strength 0.30
  4. Ronald L. Heimark · 1 shared paper, 2020 · strength 0.16
  5. Brenna A. Rheinheimer · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.